Navigation Links
Genta Clinical Programs Featured at American Society of Hematology Meeting
Date:12/4/2007

Phase 3 CLL Survival Analysis Selected for ASH Press Briefing

BERKELEY HEIGHTS, N.J., Dec. 4 /PRNewswire-FirstCall/ -- Genta Incorporated (Nasdaq: GNTA) announced that several abstracts related to the Company's clinical programs will be featured at the annual meeting of the American Society of Hematology (ASH) in Atlanta, GA during December 7-11, 2007. Programs involving Genasense(R) (oblimersen sodium) Injection, Genta's lead anticancer compound, and G4544, a new oral drug for bone diseases, were released in abstracts published in the meeting proceedings, as follows:

-- Addition of oblimersen (Bcl-2 antisense) to

fludarabine/cyclophosphamide for relapsed/refractory chronic

lymphocytic leukemia extends survival in patients who achieve CR/nPR:

Results from a randomized Phase 3 study.

Oral session: Tuesday, December 11, 2007; 7:30 am

Note: This abstract has been selected for a featured press briefing

sponsored by ASH on Sunday December 9 at 9:30 am.

-- Oblimersen (Genasense(R)), a phosphorothioate Bcl-2 antisense

oligonucleotide (ASO), can be safely administered by bolus subcutaneous

(SC) injection and brief IV Infusion. Publication.

-- Phase 1 assessment of G4544, an orally bioavailable formulation of

gallium nitrate. Publication.

About Genasense

Genasense inhibits production of Bcl-2, a protein made by cancer cells that is thought to block chemotherapy-induced apoptosis (programmed cell death). By reducing the amount of Bcl-2 in cancer cells, Genasense may enhance the effectiveness of current anticancer treatment. Genta is pursuing a broad clinical development program with Genasense
'/>"/>

SOURCE Genta Incorporated
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
2. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
3. Genta Initiates First Clinical Trial with New Oral Drug (G4544) to Treat Bone Disease
4. Genta Incorporated Announces Third Quarter 2007 Financial Results
5. Genta Completes Initial Clinical Dosing of G4544, a New Oral Drug for Bone Diseases
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... and ZURICH , May 17, 2013 ... for Science, Technology and Research (A*STAR) and Switzerland,s ... healthy volunteer has been dosed in a Phase 1 clinical ... proprietary bacteriophage Qbeta virus-like particle (VLP) technology. In this first ... novel vaccine candidate and its potential to protect against H1N1 ...
(Date:5/16/2013)...  Nektar Therapeutics, (Nasdaq: NKTR ) President and ... is scheduled to present at the upcoming 2013 UBS Global ... the Sheraton New York Hotel on Tuesday, May 21, 2013 ... be accessible via a Webcast through a link posted in ... http://www.nektar.com . This Webcast will be available for replay ...
(Date:5/16/2013)... , May 16, 2013  Alere Inc. (NYSE: ... take charge of their health at home through the merger ... dividend of $3.00 per share on its Series B Convertible ... July 15, 2013 to holders of record of Series B ... Such payment will cover the amount of all ...
Breaking Medicine Technology:A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2
... and AIDS, LOS ANGELES, Nov. 28 , WHAT: AIDS VIGIL & ... children worldwide orphaned by AIDS each day, World Vision will ... concert with World Vision,s vigils in 16 ... a 24-hour period leading up to World AIDS Day. During this ...
... CHICAGO, Nov. 28 Having hypertension, or high blood,pressure, ... Alzheimer,s,disease, according to a new study presented today at ... (RSNA)., "While hypertension is not a cause of ... on the brain that increases its vulnerability,to the effects ...
Cached Medicine Technology:Voices to Unite in Los Angeles for 6,000 Children Orphaned Daily 2High Blood Pressure May Heighten Effects of Alzheimer's Disease 2
(Date:5/18/2013)... 18 (HealthDay News) -- Just a few extra cups ... of an autoimmune liver disease known as primary sclerosing ... the Mayo Clinic in Rochester, Minn., found that drinking ... the disease, which can lead to cirrhosis of the ... does not prove a cause-and-effect relationship. "While ...
(Date:5/18/2013)... 18, 2013 In a May 14, ... Double Mastectomy After Discovering Cancer Gene,” Fox News reported ... upon learning that she carried a gene that doctors ... cancer and a 50 percent risk of ovarian cancer ... on May 16, 2013 with a blog post entitled ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 The Communities ... the special places we call home. These are the townships, ... They are the locations where the people are friendly and ... takes viewers off the highways and shares the best in ... both nations with an American sports and film celebrity. It ...
(Date:5/18/2013)... Washington DC (PRWEB) May 18, 2013 Family ... Best" designation for excellence by Follow Media Consulting, Inc. in ... award signifies the continued commitment and dedication of the areas ... lifestyle. , No one knows parenting better than Brenda Hyde, ... goal is to help parents know about the vast resources ...
(Date:5/18/2013)... 18, 2013 The “Sleep Apnea Diagnostic ... CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, ... 2017” analyzes and studies the major market drivers, restraints, ... of the World. , Browse , ... 16 Figures , 318 pagesand in-depth ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3
... Coalition for,Pulmonary Fibrosis (CPF) announced the appointment of ... has more than 25 years of experience,overseeing all ... in,leadership for non-profit foundations such as the CPF. ... including expanding CPF fundraising,capabilities and driving its overall ...
... Assume Key Management Posts as Senior Vice Presidents, ... (NYSE: AGP ) today announced the hiring ... key management positions: Linda,Whitley-Taylor has been named Executive ... AMERIGROUP as Senior Vice President, Senior,Litigation Counsel; and ...
... Robert A Weinberg is the first recipient of the science ... Georg and Eva Klein. The prize is awarded in person ... 29 January 2008. The prizewinner, who is to be a ... to Karolinska Institutet in Stockholm for two weeks to give ...
... In today,s volatile business,environment, unforeseen market shifts ... product forecasts, sales strategies and,development plans. By ... a high-functioning Competitive Intelligence group,can alert organizations ... warn,them about potential external risks., Competitive ...
... Collaboration with Harvard Medical International Provides ... Vital Global Health Information, BALTIMORE, Jan. 29 ... reach of their groundbreaking MEDEX,360m partnership with the launch ... and leisure travelers., Like the original MEDEX 360m ...
... side by side to equal the width of a human ... for administering medicines and other therapeutic agents to patients. But ... after they discharge their medical payloads has been a major ... months tracking the tiny tubes inside mice, have found some ...
Cached Medicine News:Health News:CPF Appoints Mishka Michon Chief Executive Officer 2Health News:AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services 2Health News:AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services 3Health News:Building and Sustaining Impactful Competitive Intelligence Organizations for Pharma 2Health News:MEDEX / Harvard Partnership Now Offers Affordable, New Intelligence to Individual Business & Leisure Travelers 2Health News:New nanotube findings by Stanford researchers give boost to potential biomedical applications 2Health News:New nanotube findings by Stanford researchers give boost to potential biomedical applications 3
CPTMeister is a coding reference based on the Physicians' Current Procedural Terminology (CPT) codes developed by the American Medical Association. It is an iSilo document composed of more than 2,000...
The BluefishRx ICD-9 is a Palm OS code lookup tool which incorporates the ICD-9 code set with the full and short code descriptions. It includes a multi keyword search tool with a dictionary of over 2...
MD Coder v 6.0 is a charge capture for the Palm OS and Pocket PC operating systems. We have integrated the feedback from hospitals and physicians. MD Coder v 6.0 comes in three versions: Physician Ba...
Preferred Health Resourses Practice Management System is called Remedy. The PDA version is Remedy for the Palm. It is a data capture program for your medical billing....
Medicine Products: